PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
-8.5%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.45%
AUM
$3.71B
AUM Growth
+$3.71B
(-15%)
Cap. Flow
+$5.42M
Cap. Flow
% of AUM
0.15%
Top 10 Holdings %
Top 10 Hldgs %
52.12%
Holding
129
New
22
Increased
22
Reduced
15
Closed
19
Top Buys
| 1 |
SWTX
SpringWorks Therapeutics
SWTX
|
$69.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$32.3M |
| 3 |
Solid Biosciences
SLDB
|
$29.2M |
| 4 |
Amicus Therapeutics
FOLD
|
$24.9M |
| 5 |
Y-mAbs Therapeutics
YMAB
|
$22.3M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$54.5M |
| 2 |
ARRY
Array Biopharma Inc
ARRY
|
$48.1M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$24.2M |
| 4 |
uniQure
QURE
|
$22M |
| 5 |
Teladoc Health
TDOC
|
$20.4M |
Sector Composition
| 1 | Healthcare | 93.95% |
| 2 | Financials | 0.46% |
| 3 | Consumer Discretionary | 0.18% |
| 4 | Technology | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Neurocrine Biosciences
NBIX
$13.8B
| $366M | 9.86% | 4,059,900 +36,038 | +0.9% | +$3.25M |
|
|
GBT
2
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $285M | 7.68% | 5,875,726 +100,000 | +2% | +$4.85M |
|
|
MRTX
3
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $258M | 6.96% | 3,314,606 +415,000 | +14% | +$32.3M |
|
4
Iovance Biotherapeutics
IOVA
$807M
| $200M | 5.4% | 11,014,702 -900,425 | -8% | -$16.4M |
|
|
5
Amicus Therapeutics
FOLD
$2.34B
| $197M | 5.32% | 24,609,700 +3,100,214 | +14% | +$24.9M |
|
6
BridgeBio Pharma
BBIO
$9.89B
| $144M | 3.88% | 6,706,268 | – | – |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $131M | 3.52% | 3,264,152 -243,071 | -7% | -$9.73M |
|
|
ATNX
8
DELISTED
Athenex, Inc. Common Stock
ATNX
| $131M | 3.52% | 10,735,245 +913,127 | +9% | +$11.1M |
|
|
AMRN
9
Amarin Corp
AMRN
$311M
| $116M | 3.12% | 7,636,079 +1,434,810 | +23% | +$21.8M |
|
|
DOVA
10
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
| $104M | 2.79% | 3,708,705 +155,645 | +4% | +$4.35M |
|
11
MeiraGTx Holdings
MGTX
$587M
| $103M | 2.76% | 6,433,277 +425,531 | +7% | +$6.79M |
|
|
QTNT
12
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $83.8M | 2.26% | 10,789,054 | – | – |
|
|
NVRO
13
DELISTED
NEVRO CORP.
NVRO
| $83.8M | 2.26% | 974,773 -162,992 | -14% | -$14M |
|
|
14
Solid Biosciences
SLDB
$427M
| $69.8M | 1.88% | 6,749,803 +2,822,581 | +72% | +$29.2M |
|
|
SWTX
15
DELISTED
SpringWorks Therapeutics
SWTX
| $69.8M | 1.88% | +3,217,522 | New | +$69.8M |
|
|
BPMC
16
DELISTED
Blueprint Medicines
BPMC
| $64.9M | 1.75% | 883,264 -329,467 | -27% | -$24.2M |
|
17
Zymeworks
ZYME
$1.12B
| $59.2M | 1.6% | 2,388,890 +20,000 | +0.8% | +$496K |
|
|
MYOK
18
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $59M | 1.59% | 1,130,511 +30,000 | +3% | +$1.56M |
|
19
ADMA Biologics
ADMA
$4.12B
| $51.3M | 1.38% | 11,521,102 | – | – |
|
20
Verrica Pharmaceuticals
VRCA
$52.8M
| $50.3M | 1.36% | 3,410,412 | – | – |
|
|
NEPT
21
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
| $47.8M | 1.29% | 13,436,906 +4,545,454 | +51% | +$16.2M |
|
|
VBIV
22
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $46M | 1.24% | 45,951,556 +20,000,000 | +77% | +$20M |
|
23
Kodiak Sciences
KOD
$478M
| $45.1M | 1.21% | 3,135,199 | – | – |
|
|
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $43.6M | 1.18% | 953,129 -427,042 | -31% | -$19.5M |
|
25
Allogene Therapeutics
ALLO
$251M
| $42.1M | 1.13% | 1,543,790 | – | – |
|